The diagnosis of chronic obstructive pulmonary disease according to current guidelines
10.5124/jkma.2018.61.9.539
- Author:
Hyun Jung KIM
1
;
Yeon Mok OH
Author Information
1. Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
Pulmonary disease, chronic obstructive;
Dyspnea;
Spirometry;
Respiratory function tests
- MeSH:
Anxiety;
Biomass;
Cardiovascular Diseases;
Chronic Disease;
Comorbidity;
Cough;
Depression;
Diagnosis;
Dust;
Dyspnea;
Forced Expiratory Volume;
Hospitalization;
Humans;
Korea;
Lung Neoplasms;
Mortality;
Muscle, Skeletal;
Osteoporosis;
Pulmonary Disease, Chronic Obstructive;
Respiratory Function Tests;
Risk Factors;
Smoking;
Spirometry;
Sputum;
Vital Capacity
- From:Journal of the Korean Medical Association
2018;61(9):539-544
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Chronic obstructive pulmonary disease (COPD) should be considered in any patient who has dyspnea, chronic cough or sputum production, and/or a history of exposure to risk factors for the disease, such as cigarette smoking, biomass exposure, and occupational dust. Spirometry is required to make the diagnosis, and a post-bronchodilator forced expiratory volume in one second/forced vital capacity ratio < 0.7 confirms the presence of persistent airflow limitation. The goal of COPD assessment is to determine the severity of the disease, including the severity of airflow limitation, the impact of the disease on the patient's health status, the risk of future events (such as exacerbations, hospital admission, or death), and comorbidities in order to guide therapy. Concomitant chronic diseases occur frequently in COPD patients, including cardiovascular disease, skeletal muscle dysfunction, metabolic syndrome, osteoporosis, depression, anxiety, and lung cancer. These comorbidities should be actively surveilled and treated appropriately when present, as they can independently influence mortality and hospitalization. Above all, further efforts are required to increase the diagnosis rate of COPD in Korea.
